Register Login
Welcome to the Fritsma Factor

Please join our
hemostasis discussions.

George Fritsma

MS, MLS, Lab Scientist, Educator, Author

George Fritsma is a medical laboratory scientist, educator, and author. George contributed five chapters to Keohane EM, Butina MM, Mirza KM, Walenga JM: Rodak’s Hematology; Clinical Principles and Applications, Seventh Edition, 2025, Elsevier; and is the co-author of Bennett A, Fritsma GA, Ernst DJ: Quick Guide to Blood Collection Edition 2, 2016, Marques MB, Fritsma GA: Quick Guide to Coagulation Testing Edition 3, 2015, and Reddy V, Marques MB, Fritsma GA: Quick Guide to Hematology Testing Edition 2, 2013, along with three additional titles, all published by AACC Press. He is a consultant in the Laboratory Medicine Department of Pathology at the University of Alabama at Birmingham. George is a member of the International Society on Thrombosis and Hemostasis, the International Society for Laboratory Hematology, and the American Society for Clinical Laboratory Science.

read more

Most Recent

CanVECTOR and Thrombosis Canada Conferences November 7

Thrombosis Unpacked: Decisions That Matter November 7, 2026 Join healthcare professionals from across Canada in Montreal for two days of practical, multidisciplinary education focused on difficult thrombosis and anticoagulation decisions encountered in real-world clinical care. The 2026 CanVECTOR and Thrombosis Canada Conferences bring together clinicians, researchers, pharmacists, nurses, and healthcare professionals to explore evolving evidence, controversial […]
read more

Platelets in Children

Check with your local medical library for this review on pediatric platelet development: Letunica N, Monagle P, Attard C. Platelets in children: physiological function, developmental regulation, and clinical significance in disease states. Semin Thromb Hemost. 2026. doi: 10.1055/a-2907-8906. PMID: 42442705. Abstract Platelets play a fundamental role in hemostasis; however, their phenotype, reactivity, and function vary […]
read more

Clinical Anticoagulant Measurement

Check your local medical library for these anticoagulation measurement reviews published in the November 2026 issue of Seminars in Thrombosis and Hemostasis: Favaloro EJ, Reardon B, Pasalic L. Laboratory monitoring and measuring of clinical anticoagulants. Semin Thromb Hemost. 2026;52(8):927–36. doi: 10.1055/a-2907-8841. PMID: 42442704. Abstract Haemostasis reflects a balance between procoagulant and anticoagulant forces. A relative […]
read more

October 2026 QQ: Anti-Phospholipid Antibody Summary

Our October 2026 quiz, with 32 respondents, asked, “Which is NOT an antiphospholipid antibody?” The answers reveal participants’ wisdom: Anti beta-2 glycoprotein 1: 1 (3%) Alpha-2 antiplasmin: 23 (72%) Lupus anticoagulant: 1 (3%) Antiprothrombin: 7 (22%) Anticardiolipin: 0 The only mislead that attracted respondents was antiprothrombin, a relatively rare APL that is associated with bleeding. […]
read more

Should We Publish Measurement Uncertainty Data?

Check with your medical library for MacDonald S. Measurement uncertainty in the hemostasis laboratory. Semin Thromb Hemost. 2026;52(8):899-907. doi: 10.1055/a-2723-9166. PMID: 41109209. Abstract Clinical laboratory results are inherently uncertain. Variability arises when repeating measurements of the same sample under different conditions. Measurement uncertainty (MU) is a metrological framework that quantifies this variability, enabling clinical interpretation […]
read more

Historical Review Describing Hemorrhage and Thrombosis

Check with your local medical library for Franchini M, Zani M, Focosi D. Human evolution: between hemorrhage and thrombosis. Semin Thromb Hemost. 2026. doi: 10.1055/a-2905-4308. PMID: 42398954. Abstract The human coagulation system has resulted from thousands of years of evolutionary pressure, finely balancing the competing risks of lethal hemorrhage and catastrophic thrombosis. There are several […]
read more

Illustrated Review: History of Anticoagulant Pharmacology

Here’s an open-access illustrated review that includes FXI and FXII inhibitors currently in development: Wichaiyo S. Pharmacology of anticoagulants: from heparin to novel target-specific agents. J Thromb Haemost. 2026:S1538-7836(26)00486-1. doi: 10.1016/j.jtha.2026.08.001. PMID: 42567362. Abstract Anticoagulants are the drugs of choice for the management of various thromboembolic disorders affecting both arteries and veins. This review delineates […]
read more

Questions or Comments?